The frequent loss of chromosome 6q in PCNSL, where the NF-κB inhibitor TNFAIP3 is encoded, may further contribute to NF-κB activation [27,28,29,30]. The gene discussed is TNFAIP3; the disease is primary central nervous system lymphoma.